M. Lalanne

Formulation of glycerolipidic prodrugs into PEGylated liposomes for brain delivery

P. Couvreur, V. Nicolas, N. Tsapis, 2009 .

Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route.

A. Paci, P. Couvreur, M. Besnard, 2007, International journal of pharmaceutics.

Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry.

A. Paci, G. Vassal, P. Couvreur, 2009, International journal of pharmaceutics.

A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary.

A. Paci, G. Vassal, P. Couvreur, 2011, International journal of pharmaceutics.

Strategies to increase the oral bioavailability of nucleoside analogs.

P. Couvreur, K. Andrieux, M. Lalanne, 2009, Current Medicinal Chemistry.

Formulation of Didanosine Prodrugs into PEGylated Poly(alkyl cyanoacrylate) Nanoparticles and Uptake by Brain Endothelial Cells

P. Couvreur, V. Nicolas, J. Nicolas, 2009 .

Application of thermal analysis to the study of lipidic prodrug incorporation into nanocarriers

P. Couvreur, J. Nicolas, K. Andrieux, 2009 .

Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV.

A. Paci, G. Vassal, P. Couvreur, 2007, Bioorganic & medicinal chemistry letters.